Nursing Services

research nursing for decentralized clinical trials In 2021, WEP Clinical acquired UK-based clinical nursing solutions company Wren Healthcare. Wren’s already successful business model, coupled with WEP’s US nursing capabilities, allows us to offer [...]

By |2024-03-01T09:20:08+00:00November 11th, 2021|

Case Studies

Case Studies WEP Clinical is committed to supporting companies in the pharmaceutical industry to help make much-needed medicines available to patients, physicians, hospitals and R&D centers. EAP PA-NPP Market Access Nursing Expanded Access Check out [...]

By |2024-07-16T13:49:49+01:00May 5th, 2021|

Resources

Resources All Resources| Real World Data Resources| Market Access Resources| Expanded Access Resources| Open Label Extensions Resources| Post-Approval Patient Programs Resources| Building Stakeholder Engagement Through EAPs 4th March 2024/DOWNLOAD PDF International Recognition Procedure 19th [...]

By |2024-04-04T11:46:38+01:00January 28th, 2021|

Post-Approval Named Patient Programs

Post-Approval Named Patient Programs A Post-Approval Named Patient Program (PA-NPP) allow Sponsors to make their approved medicines available in countries where they are not yet approved or commercially available. Sponsors can make their product available [...]

By |2024-07-18T15:03:33+01:00January 22nd, 2021|

EAP Versus OLE Study

EAP VERSUS OLE Both an Open Label Extension (OLE) and an Expanded Access Program (EAP) can be used to provide continued treatment access after phase 3 clinical trials have ended.To help companies understand both programs [...]

By |2024-07-16T13:38:15+01:00January 20th, 2021|

Sponsor Considerations for EAPs

SPONSOR CONSIDERATIONS FOR EAPs If your company is developing a drug that fulfils an unmet clinical need, you may have already started receiving patient enquiries about expanded access.We have put together this downloadable resource that [...]

By |2024-07-22T10:50:38+01:00December 11th, 2020|

Market Access

Market Access Strategic Consulting We specialize in access strategies for rare, oncology, gene and cell therapies across Europe, supporting clients navigating the transition from clinical development  to commercialization. Integrated Market Access Strategy A successful Market [...]

By |2024-07-18T13:19:58+01:00October 29th, 2020|

Blogs

WEP Blog All PostsNursingExpanded Access ProgramsReal World DataEarly Access Programs – What to Consider as a Patient10th October 2023/Read MoreBenefits of Homecare Nursing in Clinical Trials19th September 2023/Read MoreWhere Can an EAP Fit Into the [...]

By |2024-07-16T11:31:21+01:00May 4th, 2020|

Expanded Access Policy Templates

EXPANDED ACCESS POLICY TEMPLATES If your company is developing a drug that fulfils an unmet clinical need, you may need an Expanded Access Policy on your website.We have provided three templates, one for each of [...]

By |2024-07-16T13:39:23+01:00March 5th, 2020|

Emergency Drug Supply Service

Emergency Drug Supply Service WEP Clinical has the infrastructure to provide next day delivery of emergency medicines to hospitals throughout the EEA and Australia. We recognize the urgency behind requests [...]

By |2024-03-26T13:02:47+00:00January 13th, 2020|
Page 4 of 6
1 2 3 4 5 6
Go to Top